Malaysia
Tuberculosis profile
Population  2012 29 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 1.6 (1.2–2.1) 5.4 (4.1–7)
Mortality (HIV+TB only) 0.38 (0.29–0.48) 1.3 (1–1.7)
Prevalence  (includes HIV+TB) 29 (13–53) 101 (43–183)
Incidence  (includes HIV+TB) 24 (22–26) 80 (74–87)
Incidence (HIV+TB only) 2.3 (2.2–2.6) 8 (7.4–8.7)
Case detection, all forms (%) 93 (85–100)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 13 311 (63) Relapse 602 (41)
Smear-negative 4 941 (23) Treatment after failure 43 (3)
Smear-unknown / not done 52 (<1) Treatment after default 281 (19)
Extrapulmonary 2 945 (14) Other 535 (37)
Other 0 (0)      
Total new 21 249   Total retreatment 1 461  
           
Other (history unknown) 0        
Total new and relapse 21 851   Total cases notified 22 710  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 2.0 1.9 1.4
Age < 15 179 316 192
Laboratories 2012
Smear (per 100 000 population) 2.6
Culture (per 5 million population) 6.2
Drug susceptibility testing (per 5 million population) 0.2
Is second-line drug susceptibility testing available? Yes, in country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 79   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 71  
Retreatment 54  
TB/HIV 2012 Number (%)
TB patients with known HIV status 22 124 (97)
HIV-positive TB patients 1 347 (6)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART) 434 (32)
HIV-positive people screened for TB 6 744  
HIV-positive people provided with IPT 1 120  
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 0.1 (0–0.56) 0 (0–17)
MDR-TB cases among notified pulmonary
TB cases
18 (0–100) 0 (0–250)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB     9 132
Laboratory-confirmed MDR-TB cases     74
Patients started on MDR-TB treatment     74
Financing TB control 2013
National TB programme budget (US$ millions) 15
% Funded domestically 100%
% Funded internationally 0%
% Unfunded 0%
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-25 Data: www.who.int/tb/data